Petmed Express Inc (NASDAQ:PETS) shares were down 5.6% during mid-day trading on Friday . The stock traded as low as $15.37 and last traded at $15.46, approximately 624,526 shares traded hands during mid-day trading. A decline of 16% from the average daily volume of 745,293 shares. The stock had previously closed at $16.37.

Several analysts have issued reports on PETS shares. Craig Hallum lowered Petmed Express from a “buy” rating to a “hold” rating and set a $15.00 target price on the stock. in a research note on Friday, August 16th. BidaskClub upgraded Petmed Express from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st.

The company has a market capitalization of $311.91 million, a P/E ratio of 11.40 and a beta of 0.54. The business has a 50 day moving average of $16.15 and a 200-day moving average of $19.41.

Petmed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, July 22nd. The company reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.16). The company had revenue of $79.99 million for the quarter, compared to the consensus estimate of $85.83 million. Petmed Express had a net margin of 11.05% and a return on equity of 23.42%. The business’s revenue for the quarter was down 8.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.62 earnings per share.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 9th. Shareholders of record on Friday, August 2nd were paid a $0.27 dividend. The ex-dividend date of this dividend was Thursday, August 1st. This represents a $1.08 dividend on an annualized basis and a yield of 6.99%.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Manchester Capital Management LLC increased its stake in Petmed Express by 185.8% in the 1st quarter. Manchester Capital Management LLC now owns 1,938 shares of the company’s stock worth $44,000 after acquiring an additional 1,260 shares during the last quarter. Tyers Asset Management LLC increased its stake in Petmed Express by 20.7% in the 2nd quarter. Tyers Asset Management LLC now owns 4,356 shares of the company’s stock worth $68,000 after acquiring an additional 748 shares during the last quarter. Riverhead Capital Management LLC increased its stake in Petmed Express by 19.4% in the 2nd quarter. Riverhead Capital Management LLC now owns 4,917 shares of the company’s stock worth $77,000 after acquiring an additional 800 shares during the last quarter. Flinton Capital Management LLC increased its stake in Petmed Express by 20.7% in the 2nd quarter. Flinton Capital Management LLC now owns 5,544 shares of the company’s stock worth $87,000 after acquiring an additional 952 shares during the last quarter. Finally, Neuburgh Advisers LLC increased its stake in Petmed Express by 20.7% in the 2nd quarter. Neuburgh Advisers LLC now owns 6,732 shares of the company’s stock worth $105,000 after acquiring an additional 1,156 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Petmed Express Company Profile (NASDAQ:PETS)

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Recommended Story: What is meant by holder of record?

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.